Medicat, LLC Names Daryl Rolley New CEO

Wednesday, July 18, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

ATLANTA, July 18, 2018 /PRNewswire/ -- Medicat, LLC announces the appointment of Daryl Rolley

as its new CEO. Rolley will succeed David Berkal who has been promoted to Chair of the Board for the company. https://medicat.com/about-medicat/medicat-leadership/.

Rolley is a senior software executive who

has worked in multiple software verticals in several countries for the past 18 years, including EVP of Global Sales at Ventyx, Head of Worldwide Sales for Ariba, and SVP and GM for Asia Pacific for FreeMarkets, Inc. Rolley was an executive at McKinsey & Company earlier in his career and most recently was the Chief Commercial Officer at PRGX in Atlanta.

"I am delighted to be joining Medicat," said Rolley. "The company has built a great brand name in the University Health space over many years. I look forward to continuing the company's longstanding focus of delivering reliable, quality software solutions with outstanding customer support."

"I'm incredibly excited to have Daryl join the Medicat team. His deep experience helping lead and grow software companies will benefit all of our clients as we continue to invest heavily in our support and technology," said Berkal.

ABOUT MEDICAT: Medicat is the #1 patient health management system in the college health market with over 425 education clients serving 4 million students across 47 states and 3 countries. Medicat's fully-integrated single-database suite of products includes Practice Management with billing, Electronic Health Records, Patient Portal, Self Check-In, Enable Text, Immunization Compliance Management, Sports Medicine, and Counseling. For more information, please visit: http://www.medicat.com

 

Cision View original content:http://www.prnewswire.com/news-releases/medicat-llc-names-daryl-rolley-new-ceo-300682633.html

SOURCE Medicat, LLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store